CA1085833A - Carboxylic esters of phosphonoacetic acid - Google Patents
Carboxylic esters of phosphonoacetic acidInfo
- Publication number
- CA1085833A CA1085833A CA275,054A CA275054A CA1085833A CA 1085833 A CA1085833 A CA 1085833A CA 275054 A CA275054 A CA 275054A CA 1085833 A CA1085833 A CA 1085833A
- Authority
- CA
- Canada
- Prior art keywords
- carboxylic ester
- formula
- phosphonoacetic acid
- chemical equivalent
- whenever prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- XUYJLQHKOGNDPB-UHFFFAOYSA-N phosphonoacetic acid Chemical compound OC(=O)CP(O)(O)=O XUYJLQHKOGNDPB-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 150000001733 carboxylic acid esters Chemical class 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 32
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 125000005908 glyceryl ester group Chemical group 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 150000005691 triesters Chemical class 0.000 claims description 4
- FOCAUTSVDIKZOP-UHFFFAOYSA-M chloroacetate Chemical compound [O-]C(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-M 0.000 claims description 2
- 229940089960 chloroacetate Drugs 0.000 claims description 2
- VMZOBROUFBEGAR-UHFFFAOYSA-N tris(trimethylsilyl) phosphite Chemical compound C[Si](C)(C)OP(O[Si](C)(C)C)O[Si](C)(C)C VMZOBROUFBEGAR-UHFFFAOYSA-N 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 8
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 229910017053 inorganic salt Inorganic materials 0.000 claims 1
- 208000009889 Herpes Simplex Diseases 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 150000003863 ammonium salts Chemical class 0.000 description 6
- -1 ester compounds Chemical class 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 4
- 241000700584 Simplexvirus Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- UOUMHOPNKUNGAB-UHFFFAOYSA-N (2-oxo-2-phenylmethoxyethyl)phosphonic acid Chemical compound OP(O)(=O)CC(=O)OCC1=CC=CC=C1 UOUMHOPNKUNGAB-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
- QMRILZGPVAIQIT-UHFFFAOYSA-N (2-cyclohexyloxy-2-oxoethyl)phosphonic acid Chemical compound OP(O)(=O)CC(=O)OC1CCCCC1 QMRILZGPVAIQIT-UHFFFAOYSA-N 0.000 description 1
- GSWLMKIHGUBTJZ-UHFFFAOYSA-N (2-octoxy-2-oxoethyl)phosphonic acid Chemical compound CCCCCCCCOC(=O)CP(O)(O)=O GSWLMKIHGUBTJZ-UHFFFAOYSA-N 0.000 description 1
- IJDMZPXMWIFWON-UHFFFAOYSA-N (2-oxo-2-propoxyethyl)phosphonic acid Chemical compound CCCOC(=O)CP(O)(O)=O IJDMZPXMWIFWON-UHFFFAOYSA-N 0.000 description 1
- WRGOWLPCSIDUIP-UHFFFAOYSA-N 1,3-dihexadecoxypropan-2-yl 2-chloroacetate Chemical compound CCCCCCCCCCCCCCCCOCC(OC(=O)CCl)COCCCCCCCCCCCCCCCC WRGOWLPCSIDUIP-UHFFFAOYSA-N 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- BJNHRIOWOPQYRA-UHFFFAOYSA-N 2-adamantyl 2-chloroacetate Chemical compound C1C(C2)CC3CC1C(OC(=O)CCl)C2C3 BJNHRIOWOPQYRA-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- FLTJKNDFBHGTEZ-UHFFFAOYSA-N C[Si](C)(C)OP(O)(=O)CC(O)=O Chemical compound C[Si](C)(C)OP(O)(=O)CC(O)=O FLTJKNDFBHGTEZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000001688 Herpes Genitalis Diseases 0.000 description 1
- 206010062639 Herpes dermatitis Diseases 0.000 description 1
- 208000000903 Herpes simplex encephalitis Diseases 0.000 description 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 229910017974 NH40H Inorganic materials 0.000 description 1
- BESWGYPTDQDFAN-UHFFFAOYSA-N OP(CC(OC1C2CC(C3)CC1CC3C2)=O)(O)=O.N Chemical compound OP(CC(OC1C2CC(C3)CC1CC3C2)=O)(O)=O.N BESWGYPTDQDFAN-UHFFFAOYSA-N 0.000 description 1
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- FGYOVBMWIAVEOF-UHFFFAOYSA-N [2-(2-adamantyloxy)-2-oxoethyl]phosphonic acid Chemical compound C1C(C2)CC3CC1C(OC(=O)CP(O)(=O)O)C2C3 FGYOVBMWIAVEOF-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 230000003602 anti-herpes Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- DRHHNMHTOCKOJL-UHFFFAOYSA-N azanium carboxymethyl(hydroxy)phosphinate Chemical compound [NH4+].OP(O)(=O)CC([O-])=O DRHHNMHTOCKOJL-UHFFFAOYSA-N 0.000 description 1
- SOGXBRHOWDEKQB-UHFFFAOYSA-N benzyl 2-chloroacetate Chemical compound ClCC(=O)OCC1=CC=CC=C1 SOGXBRHOWDEKQB-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- IBFHBLOKQVCABG-UHFFFAOYSA-N cyclohexyl 2-chloroacetate Chemical compound ClCC(=O)OC1CCCCC1 IBFHBLOKQVCABG-UHFFFAOYSA-N 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000004946 genital herpes Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229960004716 idoxuridine Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- KUYMVWXKHQSIAS-UHFFFAOYSA-N tert-butyl 2-chloroacetate Chemical compound CC(C)(C)OC(=O)CCl KUYMVWXKHQSIAS-UHFFFAOYSA-N 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- HLCHESOMJVGDSJ-UHFFFAOYSA-N thiq Chemical compound C1=CC(Cl)=CC=C1CC(C(=O)N1CCC(CN2N=CN=C2)(CC1)C1CCCCC1)NC(=O)C1NCC2=CC=CC=C2C1 HLCHESOMJVGDSJ-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US681,874 | 1976-04-30 | ||
| US05/681,874 US4052439A (en) | 1976-04-30 | 1976-04-30 | Carboxylic esters of phosphonoacetic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1085833A true CA1085833A (en) | 1980-09-16 |
Family
ID=24737211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA275,054A Expired CA1085833A (en) | 1976-04-30 | 1977-03-29 | Carboxylic esters of phosphonoacetic acid |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4052439A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS52133926A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1085833A (cg-RX-API-DMAC10.html) |
| FR (1) | FR2359153A1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1553344A (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1144937A (en) * | 1977-12-22 | 1983-04-19 | Dke J.E. Helgstrand | Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections |
| DE2941384A1 (de) * | 1979-10-12 | 1981-04-23 | Bayer Ag, 5090 Leverkusen | Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| IT1150209B (it) * | 1982-03-01 | 1986-12-10 | Ausonia Farma Srl | Composto ad attivita'antivirale, procedimento per la sua preparazione e relative composizioni farmaceutiche |
| HU190449B (en) * | 1983-05-17 | 1986-09-29 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara,Hu | Process for production of derivatives of acetid acid substituated by phosphorus |
| US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| US5463092A (en) * | 1989-11-22 | 1995-10-31 | Vestar, Inc. | Lipid derivatives of phosphonacids for liposomal incorporation and method of use |
| GB9303992D0 (en) * | 1993-02-26 | 1993-04-14 | Nycomed Imaging As | Contrast agents |
| US7193106B2 (en) * | 2002-05-10 | 2007-03-20 | Idemitsu Kosan Co., Ltd. | Halogenoacetoxyadamantane derivatives and process for production thereof |
| GB0214711D0 (en) * | 2002-06-26 | 2002-08-07 | Rhodia Cons Spec Ltd | Novel phosphonocarboxylic acid esters |
| EP3405183A4 (en) | 2016-01-18 | 2019-12-11 | Arisan Therapeutics Inc. | ADAMATE DERIVATIVES FOR TREATING A FILOVIRUS INFECTION |
| WO2019018185A1 (en) | 2017-07-15 | 2019-01-24 | Arisan Therapeutics Inc. | ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3767795A (en) * | 1971-02-25 | 1973-10-23 | Abbott Lab | Method for combating certain virus infection |
-
1976
- 1976-04-30 US US05/681,874 patent/US4052439A/en not_active Expired - Lifetime
-
1977
- 1977-03-29 CA CA275,054A patent/CA1085833A/en not_active Expired
- 1977-04-25 JP JP4691677A patent/JPS52133926A/ja active Pending
- 1977-04-27 GB GB17684/77A patent/GB1553344A/en not_active Expired
- 1977-04-29 FR FR7713048A patent/FR2359153A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB1553344A (en) | 1979-09-26 |
| FR2359153B1 (cg-RX-API-DMAC10.html) | 1980-07-18 |
| JPS52133926A (en) | 1977-11-09 |
| US4052439A (en) | 1977-10-04 |
| FR2359153A1 (fr) | 1978-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI68626C (fi) | Foerfarande foer framstaellning av nya terapeutiskt aktiva hydroxikarbonylfosfonsyraderivat | |
| CA1085833A (en) | Carboxylic esters of phosphonoacetic acid | |
| JP2743099B2 (ja) | 炭素環状ヌクレオシドおよびヌクレオチド | |
| JPH02169598A (ja) | 新規なハイドロゲンホスホノジチオエート組成物 | |
| JPH06293764A (ja) | グアニン誘導体及びその製造方法及びそれを含有する製薬組成物 | |
| Herrin et al. | Synthesis and anti-herpes simplex activity of analogs of phosphonoacetic acid | |
| US3223514A (en) | Process for the control of plant growth | |
| JPS62246586A (ja) | 不飽和アミノ酸及びその製造方法 | |
| Finkelstein | The preparation of β-aminoethanephosphonic acid | |
| US3155703A (en) | Bicyclic phosphites and phosphates | |
| DE3852008T2 (de) | Verbindungen. | |
| Kosolapoff | Preparation of some mixed dialkyl phosphites | |
| US3449365A (en) | 2-imino-4-alkalidene-1,3-dithiolanes and their preparation | |
| CA1108131A (en) | Amides of phosphonoacetic acid | |
| Berlin et al. | A Convenient Synthesis of Esters of Diphenylphosphinic Acid. III1, 2 | |
| CA1069526A (en) | Phosphorus esters of phosphonoacetic acid | |
| US3666838A (en) | Propenyl and propadienylphosphonic acids 2-propadienyl-4-oxo-1,3-dioxa-2-phosphanaphthalene-2-oxide | |
| CA1108176A (en) | Arylalkyl and aryloxyalkyl phosphonates and preparation thereof | |
| CS270235B2 (en) | Method of carbocyclic purine nicleotides preparation | |
| US3350481A (en) | Monoesters of phosphonic acids | |
| EP0355899B1 (en) | Nucleotide derivatives | |
| EP0440148A1 (de) | Verwendung von Benzylphosphonsäurederivaten zur Behandlung von durch Viren verursachte Krankheiten | |
| Elmore et al. | 452. Acyl isothiocyanates. Part III. Properties of some phosphoroisothiocyanatidates | |
| EP0227918A1 (de) | Verfahren zur Herstellung von Phosphonsäuredichloriden | |
| SU694043A1 (ru) | Фосфоросодержашие симм-триазины,обладающиеиНСЕКТОАКАРицидНОй АКТиВНОСТью |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |